piperazine has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, Y | 1 |
| Gu, Q | 1 |
| Morris-Natschke, SL | 1 |
| Chen, CH | 1 |
| Lee, KH | 1 |
| Yang, L | 1 |
| Xu, X | 1 |
| Huang, Y | 1 |
| Zhang, B | 1 |
| Zeng, C | 1 |
| He, H | 1 |
| Wang, C | 1 |
| Hu, L | 1 |
2 other studies available for piperazine and HIV Coinfection
| Article | Year |
|---|---|
Incorporation of Privileged Structures into Bevirimat Can Improve Activity against Wild-Type and Bevirimat-Resistant HIV-1.
Topics: Animals; Anti-HIV Agents; Caffeic Acids; Cell Line; Chlorocebus aethiops; COS Cells; Drug Resistance | 2016 |
Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor.
Topics: HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Piperazine; Piperazines; Str | 2010 |